Vimarsana
Biggest News Aggregation in the World

Page 4 - Liso Cel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Liso Cel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Liso Cel Today - Breaking & Trending Today

Liso-cel Receives European Approval Recommendation for Relapsed/Refractory LBCL - Vimarsana News

Liso-cel Receives European Approval Recommendation for Relapsed/Refractory LBCL

The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended the approval of lisocabtagene maraleucel for the treatment of select patients with large B-cell lymphoma who relapsed within 12 months from completion of or developed refractory disease to frontline chemoimmunotherapy.